Isolating lead body for fault detection

• US 8,577,457 B2
• Filed: 07/07/2011
• Issued: 11/05/2013
• Est. Priority Date: 07/07/2011
• Status: Active Grant

• Current Assignee: Medtronic Incorporated (Medtronic Plc)
• Original Assignee: Medtronic Incorporated (Medtronic Plc)
• Inventors: Spear, Thomas H., Germanson, Nancy M., Miller, Patrick D.
• Primary Examiner(s): EVANISKO, GEORGE ROBERT
• Application Number:
  US13/177,753
• Publication Number:
  US 20130013038A1
• Time in Patent Office: 852 Days
• Field of Search: 607/7, 607/8, 607/27, 607/28
• US Class Current: 607/27
• CPC Class Codes: A61B 5/29 for permanent or long-term implantation
• CPC Class Codes: A61N 1/0587 Epicardial electrode systems; Endocardial electrodes piercing the pericardium
• CPC Class Codes: A61N 1/3706 Pacemaker parameters stimulation threshold A61N1/371
• CPC Class Codes: G01R 31/52 Testing for short-circuits, leakage current or ground faults

Abstract

Techniques are described for detecting lead-related conditions for implantable electrical leads. In some of the described embodiments, an implantable electrical lead assembly is provided with a coupling member for connecting a conductor and associated insulator(s) to an electrode/sensing element. The implantable medical device controls and performs a measurement of an electrical property of the electrical lead during periods when the conductor is decoupled from the electrode/sensing element. An indication of a lead-related condition is derived based on the measured electrical property. The lead-related condition may be associated with an insulator of a lead body of the electrical lead.

Claims

1. An implantable medical system, comprising:

an implantable medical electrical lead having;

an electrode;

a first conductor having a first distal portion;

a second conductor having a second distal portion;

an insulator disposed over the first and second conductors; and

a coupling member disposed proximate to the first and second distal portions, wherein the coupling member selectively;

couples the first conductor to the electrode while being decoupled from the second conductor in a first configuration, and

couples the first conductor to the second conductor to define a conductive pathway while decoupling the first conductor from the electrode in a second configuration; and

an implantable medical device (IMD) coupled to the implantable medical electrical lead, the IMD having circuitry configured to measure an electrical property of the conductive pathway, wherein the IMD circuitry controls the coupling member in the first configuration and the second configuration, wherein said measurement is performed by said IMD circuitry controlling the coupling member selectively to operate in the first configuration and the second configuration.

2. The implantable medical system of claim 1, wherein the measured electrical property is indicative of a lead-related condition associated with the insulation.

3. The implantable medical system of claim 1, further comprising coupling circuitry to control the coupling and decoupling of the coupling member in the first and second configuration.

4. The implantable medical system of claim 3, wherein the coupling circuitry issues a control signal to control the decoupling of the coupling member from the electrode prior to measurement of the electrical property.

5. The implantable medical system of claim 3, wherein the measured electrical property is an impedance of the conductor.

6. The implantable medical system of claim 5, wherein the IMD detects an insulation defect responsive to the impedance of the conductor exceeding a threshold value.